Basal cell carcinoma risk prediction in survivors of childhood cancer
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djaf228 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Cindy Im und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Cancer Survivors, Skin Neoplasms, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, University of Minnesota Foundation Pediatric Scholar Award.
Abstract (Originalsprache)
Background
Survivors of childhood cancer face excess risk of developing basal cell carcinoma. Age-specific basal cell carcinoma risk prediction models for survivors may support targeted screening recommendations.
Methods
We developed models predicting basal cell carcinoma risk by ages 40 and 50 years featuring detailed cancer treatment predictors, utilizing statistical and machine-learning algorithms and data from 23 166 five-year survivors in the Childhood Cancer Survivor Study, a multi-institutional retrospective cohort study. Selected models were externally validated in 5314 survivors in the St Jude Lifetime Cohort. Model discrimination and precision were evaluated using the area under the receiver operating characteristic curve (AUROC) and area under the precision-recall curve (AUPRC) and benchmarked against the current Children’s Oncology Group Long-Term Follow-Up Guidelines (COG LTFU, v6.0) for skin cancer screening.
Results
By ages 40 and 50 years, basal cell carcinoma cumulative incidence was 5% and 15% in the Childhood Cancer Survivor Study and 7% and 21% in the St Jude Lifetime Cohort, respectively. The XGBoost algorithm-based models with treatment dose-specific predictors performed best, showing good external discrimination (age 40 years: AUROC = 0.75; age 50 years: AUROC = 0.76) and precision (age 40 years: AUPRC = 0.20; age 50 years: AUPRC = 0.52), outperforming COG LTFU Guideline-directed risk stratification (age 40 years: AUROC = 0.65; age 50 years: AUROC = 0.62; age 40 years: AUPRC = 0.09; age 50 years: AUPRC = 0.26; P < .01). These novel models reclassified 37% of survivors with COG-recommended skin cancer screening as low risk by age 40 years and 29% of survivors without COG-recommended screening as moderate or high risk by age 50 years, suggesting these recommendations overestimate risk in younger survivors and miss relevant predictors (eg, attained age, chemotherapy).
Conclusions
In this study, we present validated basal cell carcinoma risk prediction models for childhood cancer survivors that outperform current practice guidelines. The associated online risk calculator can inform risk- and age-based screening recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States.
- Department of Dermatology, University of Minnesota, Minneapolis, MN, United States.
- School of Public Health, University of Alberta, Edmonton, Canada.
- Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, United States.
- Department of Radiation Physics, University of Texas at MD Anderson Cancer Center, Houston, TX, United States.
- Department of Pathology, University of Colorado, Boulder, CO, United States.
ORCID-Profile: Cindy Im, Christina Boull, Kenneth Liao, Hasibul Hasan, Yadav Sapkota, Michael A Arnold, Ashley J Housten, Judith Gebauer, Thorsten Langer, Jop C Teepen, Leontien C M Kremer, Louis S Constine, Yutaka Yasui, Melissa M Hudson, Kirsten K Ness, Gregory T Armstrong, Joseph P Neglia, Yan Yuan, Lucie M Turcotte
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- University of Minnesota Foundation Pediatric Scholar Award
- Children's Cancer Research Fund
- CIHR
- American Lebanese-Syrian Associated Charities
- St Jude Children's Research Hospital
- Cancer Center Support
Zitieren
APA
Im, C., Boull, C., Lu, Z., Liao, K., Hasan, H., Xu, L., Sapkota, Y., Howell, R. M., Arnold, M. A., Conces, M. R., Housten, A. J., Gebauer, J., Langer, T., Teepen, J. C., Kremer, L. C. M., Constine, L. S., Yasui, Y., Hudson, M. M., Ness, K. K., …, & Turcotte, L. M. (2025). Basal cell carcinoma risk prediction in survivors of childhood cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf228
Vancouver
Im C, Boull C, Lu Z, Liao K, Hasan H, Xu L, et al. Basal cell carcinoma risk prediction in survivors of childhood cancer. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf228
BibTeX
@article{Im2025,
author = {Im, Cindy and Boull, Christina and Lu, Zhe and Liao, Kenneth and Hasan, Hasibul and Xu, Linwan and Sapkota, Yadav and Howell, Rebecca M and Arnold, Michael A and Conces, Miriam R and Housten, Ashley J and Gebauer, Judith and Langer, Thorsten and Teepen, Jop C and Kremer, Leontien C M and Constine, Louis S and Yasui, Yutaka and Hudson, Melissa M and Ness, Kirsten K and Armstrong, Gregory T and Neglia, Joseph P and Yuan, Yan and Turcotte, Lucie M},
title = {Basal cell carcinoma risk prediction in survivors of childhood cancer},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djaf228}
}
EUVIMED